Assessment report – scientific discussion – for Rapilysin (reteplase) published 11/07/2006.
"A phase 1 environmental risk assessment revealed a negligible risk to the environment and therefore no further studies were required."
Environmental information for the reteplase is not available on Fass.se (2019-08-21). It is voluntary for manufacturers to publish environmental impact information on Fass.se.
Fass environmental information for Rapilysin from Actavis (downloaded 2011-07-08).
The use of amino acids, proteins and peptides is not considered to have any environmental impact.
Author: The Pharmaceutical unit of Region Stockholm